The neurosurgical and acute care management of tuberculous meningitis: evidence and current practice.
Tuberculous meningitis (TBM) is the most lethal form of tuberculosis; mortality is high and survivors are often left neurologically disabled. Several factors contribute to this poor outcome, including cerebrovascular involvement with ensuing brain ischemia, hydrocephalus and raised intracranial pressure, direct parenchymal injury, hyponatremia, and seizures. However, there is little standardisation of management with respect to these aspects of care across different centers, largely because the evidence base for much of the supportive treatment of patients with TBM is poor, leading to substantial differences in management protocols. This review emphasizes some of the uncertainties and controversies pertinent to the surgical treatment of hydrocephalus in TBM and the medical supportive management of the patient during the acute phase of the illness, with the aims of raising awareness and stimulating debate. The focus is on the management of hyponatremia, cerebral hemodynamics and intracranial pressure, medical and surgical treatment for hydrocephalus, and the intensive care management of patients in the acute severe stage of the illness. Very little data are available to address these issues with good evidence and so institutional preferences are common; this is perhaps most notable for the management of hydrocephalus, and so in this the review highlights our personal practice. The brain needs protection while the source of the illness is addressed. Without attention to these aspects of management there will always be a limit to the effectiveness of antimicrobial therapy in TBM, so there is a strong imperative for the controversies to be resolved and the limitations of our current care to be addressed. Existing protocols should be rigorously examined and novel strategies to protect the brain should be explored. To this end, a prospective, multi-disciplinary and multi-centered approach may yield answers to the questions raised in this review.
Figaji
Anthony A
AA
School of Child and Adolescent Health, Division of Neurosurgery, University of Cape Town, South Africa. Anthony.Figaji@uct.ac.za
Fieggen
A Graham
AG
D002545:Brain Ischemia / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy; D002985:Clinical Protocols; D003422:Critical Care; D019317:Evidence-Based Medicine; D006801:Humans; D006849:Hydrocephalus / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D007010:Hyponatremia / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D019586:Intracranial Hypertension / Q000382:microbiology / Q000503:physiopathology / Q000628:therapy*; D017410:Practice Guidelines as Topic; D014390:Tuberculosis, Meningeal / Q000150:complications / Q000503:physiopathology* / Q000628:therapy*